ARTICLE | Clinical News
Levitra vardenafil: Phase III; NDA filed
September 30, 2002 7:00 AM UTC
In a placebo-controlled, double-blind Phase III trial in 805 men with erectile dysfunction (ED) for more than six months, 77% of men taking 10 mg and 74% of those taking 20 mg of vardenafil reported s...